Newsmeme!
Discover News you didn't know existed
Forest Laboratories, Inc announced that an Office Action in the Reexamination of U S Patent No. 6,545,040 ('the '040 patent') was received from the U S Patent and Trademark Office ('USPTO') by Janssen Pharmaceutica N V, the patent holder of the '040 patent.
Google has introduced a new Web browser, called Chrome, aimed at wresting dominance of the browser market from Microsoft's Internet Explorer. The move takes the Google-Microsoft rivalry to a whole new level. If Google succeeds, it will be a big deal, with major ramifications for the future of the Web.
Reportlinker.com announces that a new market research report related to the Chemicals industry industry is available in its catalogue.
Forest Laboratories, Inc. announced today that an Office Action in the Reexamination of U.S. Patent No. 6,545,040 was received from the U.S. Patent and Trademark Office by Janssen Pharmaceutica N.V., the patent holder of the '040 patent.
Google has introduced a new Web browser, called Chrome, aimed at wresting dominance of the browser market from Microsoft's Internet Explorer. The move....
Health Care Service hopes patients will have better outcomes and its costs will be reduced with its purchase of disease management software maker MEDecision.
Nine Georgia hospitals rated worse than national norms on death rates for pneumonia or heart failure — a higher number than all states but California. Such mortality rates for hospitals across the nation recently were released by a federal agency, which is expanding its report cards on the quality of health care. It's the first time consumers are able to compare hospital death rates for patients ...
Google has introduced a new Web browser, called Chrome, aimed at wresting dominance of the browser market from Microsoft's Internet Explorer. The move takes the Google-Microsoft rivalry to a whole new level.
An international study led by Canadian researchers has found that telmisartan, a medication used to lower blood pressure, reduced the outcome of cardiovascular death, heart attack or stroke in people who are unable to tolerate a widely available and effective standard treatment.
The DECREASE III Study which took place in the Netherlands between June 2004 and April 2008, showed that patients treated with fluvastatin showed an improved cardiac outcome after surgery.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |